| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Consultations for Influenza-Like Illness in Primary Care in The Netherlands: A Regression Approach
|
Dolk, F. Christiaan K.
|
|
|
24 |
1 |
p. 11-18
|
artikel
|
| 2 |
Copyright/Subscription
|
|
|
|
24 |
1 |
p. v
|
artikel
|
| 3 |
Cost-Effectiveness Assessment of Monitoring Abiraterone Levels in Metastatic Castration-Resistant Prostate Cancer Patients
|
ten Ham, Renske M.T.
|
|
|
24 |
1 |
p. 121-128
|
artikel
|
| 4 |
Cost-Effectiveness of 4CMenB Infant Vaccination in England: A Comprehensive Valuation Considering the Broad Impact of Serogroup B Invasive Meningococcal Disease
|
Beck, Ekkehard
|
|
|
24 |
1 |
p. 91-104
|
artikel
|
| 5 |
Cost-Effectiveness of Pediatric Influenza Vaccination in The Netherlands
|
de Boer, Pieter T.
|
|
|
24 |
1 |
p. 19-31
|
artikel
|
| 6 |
Cost-Effectiveness of Quadrivalent Versus Trivalent Influenza Vaccination in the Dutch National Influenza Prevention Program
|
Zeevat, Florian
|
|
|
24 |
1 |
p. 3-10
|
artikel
|
| 7 |
Cost-Effectiveness of Routine Childhood Vaccination Against Seasonal Influenza in Germany
|
Scholz, Stefan M.
|
|
|
24 |
1 |
p. 32-40
|
artikel
|
| 8 |
Costs of Immunization Programs for 10 Vaccines in 94 Low- and Middle-Income Countries From 2011 to 2030
|
Sim, So Yoon
|
|
|
24 |
1 |
p. 70-77
|
artikel
|
| 9 |
Cost-Utility Analysis of a Complex Intervention to Reduce School-Based Bullying and Aggression: An Analysis of the Inclusive RCT
|
Legood, Rosa
|
|
|
24 |
1 |
p. 129-135
|
artikel
|
| 10 |
Distributional Cost-Effectiveness Analysis Comes of Age
|
Cookson, Richard
|
|
|
24 |
1 |
p. 118-120
|
artikel
|
| 11 |
Economic Benefits of Immunization for 10 Pathogens in 94 Low- and Middle-Income Countries From 2011 to 2030 Using Cost-of-Illness and Value-of-Statistical-Life Approaches
|
Watts, Elizabeth
|
|
|
24 |
1 |
p. 78-85
|
artikel
|
| 12 |
Economic Evaluation of Vaccines: Belgian Reflections on the Need for a Broader Perspective
|
Annemans, Lieven
|
|
|
24 |
1 |
p. 105-111
|
artikel
|
| 13 |
Editorial Board
|
|
|
|
24 |
1 |
p. vi
|
artikel
|
| 14 |
Evaluating Vaccination Programs That Prevent Diseases With Potentially Catastrophic Health Outcomes: How Can We Capture the Value of Risk Reduction?
|
Mauskopf, Josephine
|
|
|
24 |
1 |
p. 86-90
|
artikel
|
| 15 |
Examining Equity Effects of Health Interventions in Cost-Effectiveness Analysis: A Systematic Review
|
Avanceña, Anton L.V.
|
|
|
24 |
1 |
p. 136-143
|
artikel
|
| 16 |
Health Economics of Vaccines: From Current Practice to Future Perspectives
|
Boersma, Cornelis
|
|
|
24 |
1 |
p. 1-2
|
artikel
|
| 17 |
Informing Global Cost-Effectiveness Thresholds Using Country Investment Decisions: Human Papillomavirus Vaccine Introductions in 2006-2018
|
Jit, Mark
|
|
|
24 |
1 |
p. 61-66
|
artikel
|
| 18 |
Instructions for Authors
|
|
|
|
24 |
1 |
p. I-VIII
|
artikel
|
| 19 |
Integrating Alternative Social Value Judgments Into Cost-Effectiveness Analysis of Vaccines: An Application to Varicella-Zoster Virus Vaccination
|
Luyten, Jeroen
|
|
|
24 |
1 |
p. 41-49
|
artikel
|
| 20 |
Real-World Evidence: Understanding Sources of Variability Through Empirical Analysis
|
Crown, William H.
|
|
|
24 |
1 |
p. 116-117
|
artikel
|
| 21 |
Replication of Randomized, Controlled Trials Using Real-World Data: What Could Go Wrong?
|
Thompson, David
|
|
|
24 |
1 |
p. 112-115
|
artikel
|
| 22 |
Table of Contents
|
|
|
|
24 |
1 |
p. i-iv
|
artikel
|
| 23 |
What We Do Not Know About the Costs of Immunization Programs in Low- and Middle-Income Countries
|
Portnoy, Allison
|
|
|
24 |
1 |
p. 67-69
|
artikel
|
| 24 |
What We Know Now: An Economic Evaluation of Chickenpox Vaccination and Dose Timing Using an Agent-Based Model
|
Rafferty, Ellen R.S.
|
|
|
24 |
1 |
p. 50-60
|
artikel
|
Tijdschrift beschrijving